Effects of 1-O-hexyl-2,3,5-trimethylhydroquinone on carbon tetrachloride-induced hepatic cirrhosis in rats [0.03%]
1-己基-2,3,5-三甲基氢醌对四氯化碳致肝纤维化的治疗作用研究
Jun An,Guo-Gang Feng,Lei Huang et al.
Jun An et al.
Aim: The present study was undertaken to evaluate the effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), a synthesized vitamin E derivative, on carbon tetrachloride (CCl(4))-induced cirrhosis. ...
Effect of nucleoside analog-interferon sequential therapy on patients with acute exacerbation of chronic hepatitis B [0.03%]
核苷类似物-干扰素序贯疗法治疗慢性乙肝急性加重患者的疗效分析
Chiaki Okuse,Hiroshi Yotsuyanagi,Norie Yamada et al.
Chiaki Okuse et al.
Aim: Nucleoside analog (NA)-interferon (IFN) sequential therapy may enable the long-term control of chronic hepatitis B (CHB) and the withdrawal of the nucleoside analog. We evaluated the efficacy of NA-IFN sequential the...
Effect of chronic methylene blue administration on hypoxemia in rats with common bile duct ligation [0.03%]
甲烯兰对胆总管结扎大鼠慢性低氧血症的影响
Akiko Miyamoto,Yasumi Katsuta,Xue-Jun Zhang et al.
Akiko Miyamoto et al.
Aim: Acute administration of methylene blue (MB) can reverse hypoxemia in patients with hepatopulmonary syndrome (HPS). We evaluated the effect of chronic MB administration in common bile duct-ligated rats, which develop ...
Measurement of spleen volume is useful for distinguishing between simple steatosis and early-stage non-alcoholic steatohepatitis [0.03%]
脾体积测量有助于区分单纯性脂肪肝和早期非酒精性 steatohepatitis
Kaori Suzuki,Hiroyuki Kirikoshi,Masato Yoneda et al.
Kaori Suzuki et al.
Aim: Although non-alcoholic fatty liver disease (NAFLD) is now a common cause of chronic liver disease, discriminating between simple steatosis and non-alcoholic steatohepatitis (NASH), especially early-stage NASH, remain...
Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study [0.03%]
依折麦布治疗非酒精性脂肪肝病疗效的开放性试点研究
Masato Yoneda,Koji Fujita,Yuichi Nozaki et al.
Masato Yoneda et al.
Aim: Non-alcoholic steatohepatitis (NASH) is considered a hepatic manifestation of metabolic syndrome. However, effective drug therapy for NASH has not been established yet. In the present study, we evaluated the efficacy...
Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitis [0.03%]
脂联素作为非酒精性脂肪肝病的潜在治疗剂
Stergios A Polyzos,Jannis Kountouras,Christos Zavos
Stergios A Polyzos
Expression of the RNA-binding protein Musashi1 in adult liver stem-like cells [0.03%]
RNA结合蛋白Musashi1在成人肝脏干细胞样细胞中的表达
Etsuko Hattori,Hong-Jin Shu,Takafumi Saito et al.
Etsuko Hattori et al.
Aim: Musashi1 is an RNA-binding protein that regulates the Notch signaling pathway in stem cells. Our previous study revealed that Musashi1 is expressed in early hepatocytes during liver development in the mouse. However,...
Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009) [0.03%]
日本肝病学会第二0九年共识会议丙型肝炎的治疗指南报告
Izumi Namiki,Shuhei Nishiguchi,Keisuke Hino et al.
Izumi Namiki et al.
The consensus meeting for the diagnosis, management and treatment for hepatitis C was held in 45(th) annual meeting for the Japan Society of Hepatology (JSH) in June 2009 where the recommendations and informative statements were discussed i...
The importance of steatosis in chronic hepatitis C infection and its management: A review [0.03%]
慢性C型肝炎感染及其管理中脂肪变性的重要性的回顾性研究
Timothy J S Cross,Mohammed M Rashid,Philip A Berry et al.
Timothy J S Cross et al.
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease with approximately 180 million people infected worldwide. Hepatic steatosis is a frequent histological finding in chronic hepatitis C (CHC) infection and is 2- to 3...